CIK 1274413
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 74.80% | 54 |
| Health Care Equipment & Supplies | 14.06% | 8 |
| Insurance | 3.75% | 2 |
| Technology Hardware & Equipment | 2.94% | 2 |
| Life Sciences Tools & Services | 1.82% | 4 |
| Health Care Providers & Services | 1.27% | 4 |
| Unclassified | 0.99% | 2 |
| Software & IT Services | 0.39% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | EVMN | Evommune, Inc. | Health Care | 11.22% |
| 2 | CTNM | Contineum Therapeutics, Inc. | Health Care | 7.87% |
| 3 | SI | SHOULDER INNOVATIONS, INC. | Health Care | 5.18% |
| 4 | LLY | ELI LILLY & Co | Health Care | 4.84% |
| 5 | JNJ | JOHNSON & JOHNSON | Health Care | 3.69% |
| 6 | GILD | GILEAD SCIENCES, INC. | Health Care | 3.42% |
| 7 | UNH | UNITEDHEALTH GROUP INC | Financials | 3.35% |
| 8 | AMGN | AMGEN INC | Health Care | 2.91% |
| 9 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Health Care | 2.86% |
| 10 | INSM | INSMED Inc | Health Care | 2.80% |
75/77 names classified · sector 99.0% of weight · industry 99.0% · mkt cap 93.8%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 99.0% of the book is sector-classified (unclassified names shown, never dropped).
Only 49% of book weight classified — the grid is NOT representative of the whole book.
Classified: 49.2% of book weight (33/77 names) · unclassified 50.8%: EVMN, CTNM, SI, INSM, ARGX, BNTX, SMMT, VERA, RCUS, ROIV +34 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | EVMNEVOMMUNE INC | 589,005 | $14M | 11.2% | HOLD |
| 2 | CTNMCONTINEUM THERAPEUTICS INC | 727,587 | $10M | 7.9% | TRIM −9% |
| 3 | SISHOULDER INNOVATIONS INC | 430,407 | $6M | 5.2% | TRIM −13% |
| 4 | LLYELI LILLY & CO | 6,354 | $6M | 4.8% | TRIM −13% |
| 5 | JNJJOHNSON & JOHNSON | 18,218 | $4M | 3.7% | TRIM −10% |
| 6 | GILDGILEAD SCIENCES INC | 27,490 | $4M | 3.4% | ADD 54% |
| 7 | UNHUNITEDHEALTH GROUP INC | 14,957 | $4M | 3.4% | ADD 10% |
| 8 | AMGNAMGEN INC | 9,210 | $4M | 2.9% | TRIM −30% |
| 9 | VRTXVERTEX PHARMACEUTICALS INC | 7,007 | $3M | 2.9% | TRIM −12% |
| 10 | INSMINSMED INC | 19,668 | $3M | 2.8% | ADD 76% |
| 11 | ARGXARGENX SE | 3,564 | $3M | 2.3% | ADD 23% |
| 12 | ABBVABBVIE INC | 12,200 | $3M | 2.2% | TRIM −27% |
| 13 | ABTABBOTT LABS | 25,578 | $3M | 2.2% | ADD 9% |
| 14 | MRKMERCK & CO INC | 21,480 | $3M | 2.1% | HOLD |
| 15 | REGNREGENERON PHARMACEUTICALS | 2,919 | $2M | 2.1% | TRIM −21% |
| 16 | ISRGINTUITIVE SURGICAL INC | 5,250 | $2M | 2.0% | ADD 8% |
| 17 | BSXBOSTON SCIENTIFIC CORP | 34,780 | $2M | 1.8% | ADD 26% |
| 18 | BNTXBIONTECH SE | 22,164 | $2M | 1.7% | ADD 29% |
| 19 | SYKSTRYKER CORPORATION | 5,874 | $2M | 1.6% | TRIM −10% |
| 20 | DHRDANAHER CORP DEL | 9,597 | $2M | 1.5% | TRIM −9% |
| 21 | TMOTHERMO FISHER SCIENTIFIC INC | 3,508 | $2M | 1.4% | TRIM −10% |
| 22 | DXCMDEXCOM | 23,231 | $1M | 1.2% | TRIM −19% |
| 23 | IQVIQVIA HLDGS INC | 8,307 | $1M | 1.2% | NEW |
| 24 | SMMTSUMMIT THERAPEUTICS INC | 69,615 | $1M | 1.2% | TRIM −13% |
| 25 | EWEDWARDS LIFESCIENCES CORP | 17,338 | $1M | 1.2% | HOLD |
| 26 | BMYBRISTOL-MYERS SQUIBB CO | 21,150 | $1M | 1.1% | NEW |
| 27 | UTHRUnited Therapeutics Corp. | 1,710 | $1M | 0.9% | HOLD |
| 28 | VERAVERA THERAPEUTICS INC | 25,573 | $1M | 0.9% | TRIM −31% |
| 29 | RCUSARCUS BIOSCIENCES INC | 45,070 | $1M | 0.9% | TRIM −21% |
| 30 | ROIVROIVANT SCIENCES LTD | 32,500 | $1M | 0.8% | TRIM −28% |
| 31 | MDTMEDTRONIC PLC | 11,100 | $961,815 | 0.8% | NEW |
| 32 | TRVITREVI THERAPEUTICS INC | 74,446 | $939,499 | 0.8% | TRIM −12% |
| 33 | COGTCOGENT BIOSCIENCES INC | 22,140 | $902,398 | 0.7% | TRIM −32% |
| 34 | MLYSMINERALYS THERAPEUTICS INC | 31,618 | $895,135 | 0.7% | HOLD |
| 35 | ALNYALNYLAM PHARMACEUTICALS INC | 2,310 | $864,232 | 0.7% | TRIM −23% |
| 36 | TARSTARSUS PHARMACEUTICALS INC | 11,272 | $852,463 | 0.7% | TRIM −24% |
| 37 | RAPPRAPPORT THERAPEUTICS INC | 25,421 | $835,005 | 0.7% | TRIM −35% |
| 38 | NKTRNEKTAR THERAPEUTICS | 10,851 | $820,662 | 0.7% | TRIM −20% |
| 39 | SNDXSYNDAX PHARMACEUTICALS INC | 31,680 | $787,466 | 0.7% | TRIM −48% |
| 40 | ARDXARDELYX INC | 122,394 | $781,060 | 0.6% | NEW |
| 41 | PFEPFIZER INC | 27,500 | $772,200 | 0.6% | HOLD |
| 42 | BOLDBOUNDLESS BIO INC | 678,574 | $746,431 | 0.6% | HOLD |
| 43 | ASNDASCENDIS PHARMA A/S | 2,800 | $728,276 | 0.6% | TRIM −14% |
| 44 | AVBPARRIVENT BIOPHARMA INC | 30,013 | $720,430 | 0.6% | TRIM −22% |
| 45 | GPCRSTRUCTURE THERAPEUTICS INC | 14,102 | $710,805 | 0.6% | TRIM −41% |
| 46 | IMTXIMMATICS N.V | 66,830 | $692,687 | 0.6% | ADD 6% |
| 47 | BBIOBRIDGEBIO PHARMA INC | 8,100 | $687,276 | 0.6% | TRIM −27% |
| 48 | SPRYARS PHARMACEUTICALS INC | 79,150 | $676,672 | 0.6% | ADD 166% |
| 49 | ONCBEONE MEDICINES LTD | 1,870 | $631,061 | 0.5% | TRIM −30% |
| 50 | TECXTECTONIC THERAPEUTIC INC | 19,059 | $628,215 | 0.5% | TRIM −55% |
| 51 | IONSIONIS PHARMACEUTICALS INC | 7,200 | $617,240 | 0.5% | TRIM −14% |
| 52 | BMRNBIOMARIN PHARMACEUTICAL INC | 9,450 | $607,268 | 0.5% | TRIM −13% |
| 53 | KURAKURA ONCOLOGY INC | 71,480 | $606,010 | 0.5% | ADD 32% |
| 54 | PRVAPRIVIA HEALTH GROUP INC | 27,136 | $558,188 | 0.5% | ADD 4% |
| 55 | CYTKCYTOKINETICS INC | 7,300 | $544,614 | 0.5% | ADD 24% |
| 56 | PTCTPTC THERAPEUTICS INC | 6,650 | $515,063 | 0.4% | TRIM −14% |
| 57 | QUREUNIQURE NV | 29,245 | $499,411 | 0.4% | TRIM −4% |
| 58 | AGMBAGOMAB THERAPEUTICS NV | 43,500 | $477,295 | 0.4% | NEW |
| 59 | ALHCALIGNMENT HEALTHCARE INC | 26,911 | $474,172 | 0.4% | TRIM −15% |
| 60 | HNGEHINGE HEALTH INC | 12,244 | $472,129 | 0.4% | TRIM −14% |
| 61 | RDNTRADNET INC | 7,999 | $447,064 | 0.4% | TRIM −27% |
| 62 | RPRXROYALTY PHARMA PLC | 7,200 | $393,834 | 0.3% | TRIM −15% |
| 63 | BIIBBIOGEN INC | 1,850 | $385,910 | 0.3% | TRIM −14% |
| 64 | INSPINSPIRE MED SYS INC | 7,225 | $372,666 | 0.3% | HOLD |
| 65 | JAZZJAZZ PHARMACEUTICALS PLC | 1,750 | $371,294 | 0.3% | TRIM −15% |
| 66 | NBIXNEUROCRINE BIOSCIENCES INC | 2,300 | $343,841 | 0.3% | TRIM −14% |
| 67 | ORICORIC PHARMACEUTICALS INC | 23,500 | $332,651 | 0.3% | ADD 5% |
| 68 | OMDAOMADA HEALTH INC | 25,620 | $322,043 | 0.3% | TRIM −30% |
| 69 | ABVXABIVAX SA | 2,340 | $297,861 | 0.2% | NEW |
| 70 | ILMNILLUMINA INC | 2,132 | $296,071 | 0.2% | TRIM −14% |
| 71 | AXSMAXSOME THERAPEUTICS INC. | 1,500 | $289,869 | 0.2% | TRIM −14% |
| 72 | INCYINCYTE CORP | 2,350 | $254,124 | 0.2% | TRIM −15% |
| 73 | MRNAMODERNA INC | 4,350 | $247,904 | 0.2% | TRIM −13% |
| 74 | MEDPMEDPACE HLDGS INC | 430 | $228,090 | 0.2% | NEW |
| 75 | GHGUARDANT HEALTH INC | 1,980 | $205,523 | 0.2% | NEW |
| 76 | RVMDREVOLUTION MEDICINES INC | 1,830 | $202,280 | 0.2% | NEW |
| 77 | PALIPALISADE BIO INC | 88,000 | $172,375 | 0.1% | NEW |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| EVMNEVOMMUNE INC | — | — | — | — | 589K | 589K | $14M |
| CTNMCONTINEUM THERAPEUTICS INC | 801K | 801K | 801K | 801K | 801K | 728K | $10M |
| SISHOULDER INNOVATIONS INC | — | — | — | 430K | 492K | 430K | $6M |
| LLYELI LILLY & CO | 13K | 9K | 9K | 9K | 7K | 6K | $6M |
| JNJJOHNSON & JOHNSON | 23K | 22K | 19K | 15K | 20K | 18K | $4M |
| GILDGILEAD SCIENCES INC | 51K | 32K | 20K | 20K | 18K | 27K | $4M |
| UNHUNITEDHEALTH GROUP INC | 15K | 13K | 17K | 14K | 14K | 15K | $4M |
| AMGNAMGEN INC | 13K | 10K | 11K | 10K | 13K | 9K | $4M |
| VRTXVERTEX PHARMACEUTICALS INC | 4K | 5K | 7K | 8K | 8K | 7K | $3M |
| INSMINSMED INC | 7K | 15K | 15K | 13K | 11K | 20K | $3M |
| ARGXARGENX SE | 3K | 3K | 4K | 4K | 3K | 4K | $3M |
| ABBVABBVIE INC | 19K | 15K | 15K | 15K | 17K | 12K | $3M |
| ABTABBOTT LABS | 24K | 19K | 15K | 17K | 23K | 26K | $3M |
| MRKMERCK & CO INC | 25K | 27K | 21K | 16K | 21K | 21K | $3M |
| REGNREGENERON PHARMACEUTICALS | 3K | 3K | 3K | 4K | 4K | 3K | $2M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
